Expand ALDX Menu
ALDX MENU

ALDX Latest Press Releases

-- July 24, 2025 --

Aldeyra Therapeutics Receives Orphan Designation From European Medicines Agency For ADX-2191 In Treatment Of Inherited Retinal Dystrophies Including Retinitis Pigmentosa Benzinga Newsdesk 7:06 AM
Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Inherited Retinal Dystrophies including Retinitis Pigmentosa Business Wire 7:00 AM

-- July 17, 2025 --

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease Business Wire 7:00 AM

-- June 26, 2025 --

Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma Business Wire 7:00 AM

-- June 17, 2025 --

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease Business Wire 7:00 AM

-- May 29, 2025 --

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference Business Wire 7:01 AM

-- May 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX Globe Newswire 10:00 AM

-- May 14, 2025 --

Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM

-- May 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX Globe Newswire 1:22 PM

-- May 12, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX PRNewswire 5:46 PM

-- May 7, 2025 --

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with Losses may have been affected by Securities Violations - Contact BFA Law (NASDAQ:ALDX) Globe Newswire 8:46 AM

-- May 6, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX PRNewswire 4:02 PM

-- May 5, 2025 --

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission Business Wire 6:34 PM
Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap Business Wire 4:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX Globe Newswire 2:12 PM
ALDX SECURITIES ALERT: Lose Money on Aldeyra Therapeutics, Inc.? Contact BFA Law about Securities Investigation (NASDAQ:ALDX) Globe Newswire 7:53 AM

-- May 3, 2025 --

ALDX INQUIRY NOTICE: Aldeyra Therapeutics (NASDAQ:ALDX) Investors may have been affected by Securities Violations -- Contact BFA Law Globe Newswire 7:18 AM

-- May 1, 2025 --

ALDX INVESTIGATION: Aldeyra Therapeutics (NASDAQ:ALDX) Investors with Losses are Urged to Contact BFA Law about its Investigation into the Company Globe Newswire 8:08 AM

-- April 29, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX Globe Newswire 11:16 AM
ALDX Investors Have Opportunity to Join Aldeyra Therapeutics, Inc. Fraud Investigation with the Schall Law Firm PRNewswire 9:49 AM
ALDX ALERT: Aldeyra Therapeutics (NASDAQ:ALDX) Investors are Reminded of Pending Securities Investigation - Contact BFA Law Globe Newswire 8:41 AM

-- April 28, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX PRNewswire 6:06 PM

-- April 27, 2025 --

ALDX SHAREHOLDER REVIEW: Aldeyra Therapeutics (NASDAQ:ALDX) is being Investigated after 75% Stock Drop - Investors are Urged to Contact BFA Law Globe Newswire 8:20 AM

-- April 25, 2025 --

Rosen Law Firm Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation - ALDX Business Wire 5:49 PM
ALDX SHAREHOLDERS: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) 75% Stock Drop Triggers Investigation - Contact BFA Law if You Lost Money Globe Newswire 7:36 AM

-- April 23, 2025 --

LEGAL NOTICE: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Investors are Notified of the Pending Securities Investigation - Contact BFA Law Globe Newswire 8:18 AM

-- April 22, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX PRNewswire 3:58 PM

-- April 21, 2025 --

ALDX Investors Have Opportunity to Join Aldeyra Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Business Wire 6:08 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX Globe Newswire 2:30 PM
ALDX LEGAL REMINDER: Did Aldeyra Therapeutics, Inc. Commit Securities Violations? Contact BFA Law (NASDAQ:ALDX) Globe Newswire 8:33 AM

-- April 19, 2025 --

ALDX INVESTOR NEWS: Aldeyra Therapeutics, Inc. Investors may be able to Recover Losses in Class Action Investigation -- Contact BFA Law (NASDAQ:ALDX) Globe Newswire 8:06 AM

-- April 17, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX Globe Newswire 12:47 PM
ALDX INVESTOR INVESTIGATION: Aldeyra Therapeutics, Inc. Investors are Reminded of the Ongoing Securities Investigation - Contact BFA Law (NASDAQ:ALDX) Globe Newswire 8:36 AM
Aldeyra Therapeutics Appoints Chip Clark to Board of Directors Business Wire 7:00 AM

-- April 15, 2025 --

Bragar Eagel & Squire, P.C. Is Investigating TechTarget and Aldeyra and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
ALDX INVESTIGATION NOTICE: Suffer Losses on Aldeyra Therapeutics, Inc.? Contact BFA Law about the Securities Investigation (NASDAQ:ALDX) Globe Newswire 8:18 AM

-- April 14, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX PRNewswire 6:19 PM

-- April 13, 2025 --

ALDX STOCK REMINDER: The Aldeyra Therapeutics, Inc. Investigation is Ongoing - Investors are Urged to Contact BFA Law (NASDAQ:ALDX) Globe Newswire 7:08 AM

-- April 12, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX Globe Newswire 9:30 AM

-- April 11, 2025 --

ALDX STOCK NOTIFICATION: Did Aldeyra Therapeutics, Inc. Violate the Securities Laws? Investors are Notified to Contact BFA Law (NASDAQ:ALDX) Globe Newswire 7:43 AM

-- April 10, 2025 --

ALDEYRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Aldeyra Therapeutics, Inc. on Behalf of Aldeyra Stockholders and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman PRNewswire 9:30 AM

-- April 9, 2025 --

Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman Globe Newswire 5:00 PM
ALDX CLASS NOTICE: An Investigation has been Initiated on behalf of Aldeyra Therapeutics, Inc. Investors -- Contact BFA Law if You Lost Money (NASDAQ:ALDX) Globe Newswire 8:34 AM

-- April 7, 2025 --

ALDX SECURITIES REPORT: Aldeyra Therapeutics, Inc. Securities Investigation Could Allow Investors to Recover Losses; Contact BFA Law (NASDAQ:ALDX) Globe Newswire 8:16 AM

-- April 5, 2025 --

ALDX SECURITIES ALERT: Aldeyra Therapeutics, Inc. Investors are Notified of the Ongoing Securities Investigation; Contact BFA Law (NASDAQ:ALDX) Globe Newswire 7:11 AM

-- April 4, 2025 --

Kirby McInerney LLP Announces Investigation of Possible Claims Against Aldeyra Therapeutics, Inc. (ALDX) on Behalf of Investors Globe Newswire 8:00 PM
INVESTOR ALERT: Investigation of Aldeyra Therapeutics, Inc. (ALDX) Announced by Holzer & Holzer, LLC Globe Newswire 12:57 PM

-- April 3, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX Globe Newswire 5:03 PM
ALDX BREAKING NEWS: BFA Law Announces an Investigation into Aldeyra Therapeutics, Inc. 75% Stock Drop; Investors are Notified to Contact BFA Law Business Wire 12:34 PM
ALDX BREAKING NEWS: Aldeyra Therapeutics, Inc. 75% Stock Drop Triggers Securities Investigation; Contact BFA Law if You Lost Money (NASDAQ:ALDX) Globe Newswire 11:58 AM
BREAKING: Block & Leviton Investigating Aldeyra Therapeutics (ALDX) For Securities Fraud After Shares Fall Nearly 75%; Investors Encouraged to Contact the Firm Globe Newswire 11:07 AM
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease Business Wire 8:00 AM

-- March 10, 2025 --

Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference Business Wire 7:00 AM